Updated: January 4, 2026

Sertraline Shortage Update: What Patients Need to Know in 2026

Author

Peter Daggett

Summarize with AI

Current Status: Is Sertraline in Shortage Right Now?
Shortage Timeline: What Happened and When
Why Do Localized Shortages Still Happen?
Which Sertraline Presentations Are Most Affected?
What Should Patients Do Right Now?
The Outlook for Sertraline in 2026

Is sertraline still in shortage in 2026? Get the latest on sertraline availability, which dosages are affected, and what patients can do right now.

If you've had trouble finding sertraline — or if your pharmacist has told you it's on back order — you're not alone. Sertraline (brand name Zoloft) has experienced supply disruptions that have left millions of patients scrambling to fill their prescriptions. This is the 2026 update.

Current Status: Is Sertraline in Shortage Right Now?

As of early 2026, sertraline is not listed as an active nationwide shortage on the FDA Drug Shortage Database. Multiple manufacturers continue to produce it, including Accord, Cipla USA, Lupin, Exelan Pharmaceuticals, and Pfizer (brand Zoloft).

However: localized stock gaps and specific-strength shortages remain a real problem for patients in many parts of the country. A drug being "off the national shortage list" does not mean it is reliably available at every pharmacy. If your local pharmacies are consistently out of your strength or count, that's a real supply problem — even if it's not tracked federally.

Shortage Timeline: What Happened and When

Here's how the sertraline supply situation has evolved:

May 2020: ASHP first reported an active sertraline tablet shortage. COVID-19 drove unprecedented demand for antidepressants.
2020–2022: Widespread supply disruptions. Multiple manufacturers struggled to keep up with surging demand; antidepressant prescriptions rose sharply nationwide.
October 2021: Greenstone discontinued sertraline tablets, removing a significant producer from the market.
2022–2023: ASHP officially closed the sertraline shortage. National supply stabilized but some pharmacies continued reporting inconsistent stock.
2024–2025: Strides Pharma discontinued 25 mg, 50 mg, and 100 mg sertraline tablets (commercial decision). Further reduction in the generic manufacturer pool.
2026: No active FDA shortage. National supply is better than 2020-2021 peaks. Remaining manufacturers (Accord, Cipla, Lupin, Exelan, Pfizer) are actively producing. Spot shortages at individual pharmacies persist.

Why Do Localized Shortages Still Happen?

Even with multiple manufacturers producing sertraline, stock gaps occur because:

Each pharmacy chain has exclusive contracts with certain generic manufacturers. If that manufacturer backorders a presentation, the pharmacy has nothing to dispense.
Sertraline remains one of the highest-demand generic drugs in the U.S. — small supply fluctuations get amplified quickly.
Generic drug supply chains are thin by design — low margins mean minimal buffer inventory.

Which Sertraline Presentations Are Most Affected?

When stock gaps occur, these tend to be the most affected:

25 mg and 50 mg tablets — highest demand as starting doses
Oral solution (20 mg/mL) — fewer manufacturers, harder to find at retail
100 mg bottles of specific counts (e.g., 30 count vs 90 count) — may be available in one pack size but not another

What Should Patients Do Right Now?

Use medfinder to locate your prescription. Rather than calling pharmacies yourself, medfinder contacts pharmacies near you and texts you which ones can fill your sertraline prescription. It covers all strengths and dosage forms.
Refill early. Don't wait until your last pill. Most insurers will allow a refill when you have 5–7 days of supply remaining. Request early refills and communicate your supply situation to your pharmacist.
Switch to mail-order. Mail-order pharmacies have more predictable inventory than retail stores. Ask your prescriber to write a 90-day supply and enroll through your insurer's mail-order program.
Never stop abruptly. If you're running out, contact your prescriber before you're out. Stopping sertraline abruptly can cause withdrawal symptoms including dizziness, nausea, irritability, and electric shock sensations.

The Outlook for Sertraline in 2026

The overall drug shortage picture in the U.S. is improving: the number of new shortages in 2025 hit its lowest level in nearly 20 years, according to ASHP. For sertraline specifically, the situation is more stable than during 2020–2022. However, patients should remain vigilant about refilling early and knowing where to find stock quickly.

Also: How to Find Sertraline in Stock Near You (Tools + Tips).

Frequently Asked Questions

Sertraline is not on the FDA's active nationwide shortage list as of 2026. However, localized stock gaps remain common, particularly for 25 mg and 50 mg tablets. Multiple manufacturers are producing sertraline, but distribution unevenness means some pharmacies still regularly run out.

ASHP first reported an active sertraline tablet shortage in May 2020, driven by a massive surge in antidepressant demand during the COVID-19 pandemic. Manufacturer exits (Greenstone in October 2021; Strides Pharma more recently) further reduced the supply pool.

The 25 mg and 50 mg tablets are the most commonly prescribed starting doses and tend to experience the most frequent stock gaps. The oral solution (20 mg/mL) is also harder to find since fewer manufacturers produce it.

The trend is positive — the number of new U.S. drug shortages reached its lowest level in nearly 20 years in 2025, according to ASHP. For sertraline, multiple manufacturers remain active. While localized gaps will likely persist, a return to the severe 2020-2021 shortage conditions seems unlikely barring new disruptions.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards